Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1761-1770 of 2905 for cancer

Edit search filters
  1. A Study Of The Safety And Effectiveness Of Palbociclib Plus Cetuximab Versus Cetuximab Alone To Treat Head And Neck Cancer

    Rochester, MN

  2. A Study Comparing Vaccinia Virus Based Immune System Therapy Plus Sorafenib Versus Sorafenib Alone To Treat Liver Cell Cancer

    Scottsdale/Phoenix, AZ

  3. A Study To Evaluate Trifluridine/Tipiracil Combined With Bevacizumab Vs Trifluridine/Tipiracil To Treat Patients With Refractory Metastatic Colorectal Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  4. Health And Wellness Coaching To Improve Adherence To Healthy Habits And Treatment Plans In Papillary And Follicular Thyroid Cancer Survivors

    Jacksonville, FL

  5. A Study To Evaluate Regorafenib With Cetuximab Or Panitumumab To Treat Unresectable, Locally Advanced, Or Metastatic Colorectal Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  6. Radiation Therapy With Durvalumab Or Cetuximab To Treat Patients With Locoregionally Advanced Head And Neck Cancer Who Cannot Take Cisplatin

    Rochester, MN

  7. A Study Of Rociletinib (CO-1686) For Patients With A Mutant Form Of Non-Small Cell Lung Cancer.

    Scottsdale/Phoenix, AZ

  8. Everolimus And Letrozole In Treating Patients With Recurrent Hormone Receptor Positive Ovarian, Fallopian Tube, Or Primary Peritoneal Cavity Cancer

    Jacksonville, FL, Rochester, MN

  9. A Study To Estimate The Clinical Benefit Of REGN2810 For Patients With Advanced Squamous Cell Skin Cancer

    Scottsdale/Phoenix, AZ

  10. Nab-paclitaxel And Gemcitabine Vs Gemcitabine Alone As Adjuvant Therapy For Patients With Resected Pancreatic Cancer (The "Apact" Study)

    Scottsdale/Phoenix, AZ, Rochester, MN

.

Mayo Clinic Footer